Visit https://www.peervoice.com/GMF860 to view the entire programme with slides. After completing “Shifting the Treatment Paradigm in Type 2 Diabetes and CKD: The Role of Nonsteroidal MRAs”, participants will be able to: Evaluate recent clinical data for novel strategies for the management of type 2 diabetes (T2DM) and chronic kidney disease (CKD); Identify patient and disease characteristics that may influence treatment decision-making for patients with T2DM and CKD; Translate current and emerging clinical evidence into optimal treatment plans for patients with T2DM and CKD.